GHTF posts final revised labelling guidance
This article was originally published in Clinica
The Global Harmonization Task Force has posted the final document on Labelling for Medical Devices. The document was prepared by GHTF study group 1 and is intended to provide non-binding guidance to regulatory authorities. It supersedes the previous version, GHTF/SG1/N9:2000 Labelling for Medical Devices of February 24, 2000. It also includes added guidance on the labelling of IVDs.
You may also be interested in...
A recent Department of Health and Human Services proposal to review regulations every 10 years may mean good things for the device industry, said David Hoffmeister, partner, Wilson Sonsini Goodrich & Rosati.
Aker BioMarine seeks supplement firms to use its EPA/DHA innovation bound by lysophosphatidylcholine to enable the fatty acids to pass through the blood-brain and blood-retinal barriers and boost of eye and brain health benefits. It will submit an NDI notificaion in the US during 2022.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.